Patient Convenience is Key to Diabetes Medical Device
Achieving the Holy Grail of T1DM Treatment
Whereas T2DM patients have a multitude of treatments available to them to assist in the management of their disease, those with T1DM are primarily reliant on insulin and insulin analogs to control their blood glucose levels. Though great strides have been made in developing short-, long-, and intermediate-acting insulins to optimize glucose control, T1DM patients have long been subject to hyperglycemia (post-meal) and hypoglycemia (overnight). In this article, John McNamara analyzes why the closed loop systems promise both clinical and lifestyle benefits over manual management methods. But they are far from becoming the standard of care for T1DM patients given their relative nascency in the market. Nevertheless, many clinicians and researchers agree that perfecting this closed-loop paradigm represents the "holy grail" of T1DM disease management.SCIENTIA ADVISORS, LLC | info@scientiaadv.com
55 Cambridge Parkway, Suite 300E, Cambridge MA 02142 | Phone: 617-299-3000 | Fax: 617-812-0315
© 2012 Scientia Advisors LLC
